Methods This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to identify and evaluate in vitro studies investigating the effects of glucagon-like peptide-1 receptor agonists and their analogues on human mesenchymal stem cell functions, including proliferation, differentiation, signaling, apoptosis, and tissue-specific applications
At steady state, the peaks and troughs stabilize into a predictable rhythm
This follow-up window captures meaningful changes without being so frequent that normal fluctuations cloud the picture
Frequently Asked Questions How long until I notice a difference
Some GLP-1 receptor agonists are currently approved as a weight-loss drugs to treat people with a body mass index (BMI) score in the overweight or obese range, under certain circumstances
Retatrutide activates three (GLP-1 + GIP + glucagon)